CYTK:NASDAQ
Cytokinetics, Inc.
$65.64
arrow_downward
-0.79%(-0.52) 1D
$65.90
arrow_upward
+0.40% (+0.26)bedtimeAfter hours
Closed: Sep 29, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$65.91
High
$66.52
Low
$64.38
Mkt. cap
9.13B
Avg. vol.
1.92M
Volume
2.40M
52-wk high
$88.31
52-wk low
$53.57
EPS
-$7.22
Beta
0.36
Shares outstanding
139.02M
No. of employees
673
Open
$65.91
High
$66.52
Low
$64.38
Mkt. cap
9.13B
Avg. vol.
1.92M
Volume
2.40M
52-wk high
$88.31
52-wk low
$53.57
EPS
-$7.22
Beta
0.36
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
Investing.com Canada
·
16 hours ago
Form 4 Cytokinetics Inc For: 29 September By Investing.com
Investing.com
·
17 hours ago
Cytokinetics CEO Robert Blum sells $490,949 in stock
AD HOC NEWS
·
1 day ago
Cytokinetics stock gains 2.15 percent as analysts target USD 109.90
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com